Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
A single 6-year-old boy presenting with the hallmark triad of vascularizing keratitis, ichthyosiform erythrokeratoderma and sensorineural hearing loss, as well as congenital atrichia, was found to carry a heterozygous GJB6 c.110T>A (p.Val37Glu) variant, without concomitant GJB2 pathogenic changes (1 proband) (PMID:15140211). This expands the genetic heterogeneity of KID syndrome by implicating connexin-30 in a phenotype classically attributed to connexin-26.
Functional characterization of Cx30 V37E in keratinocyte and HeLa models demonstrated impaired plasma membrane trafficking and failure to form gap junction plaques, consistent with a loss-of-function defect (PMID:12419304). Subsequent studies revealed that V37E-Cx30 is retained in the endoplasmic reticulum and triggers apoptosis in epidermal cells, highlighting a pathogenic mechanism distinct from other Cx30 mutations (PMID:24522190).
Gene–Disease AssociationLimitedSingle unrelated proband with heterozygous GJB6 V37E variant ([PMID:15140211]); no segregation data Genetic EvidenceLimitedOne proband reported with c.110T>A (p.Val37Glu) in GJB6 leading to KID syndrome ([PMID:15140211]) Functional EvidenceModerateIn vitro studies show impaired trafficking and apoptotic gain-of-function for V37E-Cx30 in keratinocytes and HeLa cells ([PMID:12419304; PMID:24522190]) |